Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Califf Lowering FDA Drawbridge To Work With External Expertise

This article was originally published in The Tan Sheet

Executive Summary

In Pink Sheet's exclusive interview, new commissioner says FDA will tap knowledge beyond its walls, without compromising agency independence.

Advertisement

Related Content

US FDA Hiring Initiative Aims To Get Scientific Staff More Involved In Recruitment
Califf Sets Exit At FDA, Ostroff Could Return To Acting Commissioner Post
Don't Rush To Reorganize FDA, McClellan Says
FDA Talent Hunt: Is Recruiting From Academia Better Than Industry?
Califf Supports Combo Products Pathway At Confirmation Hearing
Can Google Enhance Drug Safety Surveillance?
Show Me The Money: FDA Recruitment Efforts Challenged By Government Salaries
Patient-Focused Drug Development At 10: Where Does It Go From Here?
FDA Conflict Of Interest Screening Could Get Streamlined As Patient Involvement Increases
Good Neighbors Make Good Regulatory Science Centers, FDA Decides
Advertisement
UsernamePublicRestriction

Register

PS108289

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel